首页>
外国专利>
Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes
Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes
展开▼
机译:罗伊氏乳杆菌 I> GMNL-89治疗2型糖尿病的组成和方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Present invention features a novel use of Lactobacillus for treating type 2 diabetes, wherein the Lactobacillus is Lactobacillus reuteri GMNL-89 with the deposition numbers of BCRC 910340 and CCTCC M 207154 and comprises of live, dead bacteria or supernatant of the bacterial culture(s) and a pharmaceutically acceptable vehicle. The invention also discloses the efficacies of the indicated Lactobacillus strain including anti-oxidative enzyme activity, anti-inflammation, reduction of blood glucose level, reduction of triglycerides, reduction of total cholesterol, reduction of LDL, increase of HDL and improve insulin utilization.
展开▼
机译:本发明的特征是乳杆菌 I>在治疗2型糖尿病中的新用途,其中乳杆菌 I>是罗伊氏乳杆菌 I> GMNL-89,其沉积数目为BCRC 910340和CCTCC M 207154,由活的,死的细菌或细菌培养物的上清液和药学上可接受的载体组成。本发明还公开了所示的乳酸杆菌菌株的功效,包括抗氧化酶活性,抗炎,降低血糖水平,降低甘油三酸酯,降低总胆固醇,降低LDL,增加LDL。高密度脂蛋白和提高胰岛素利用率。
展开▼